Unresectable Metastatic Pancreatic Cancer

Brian Berheide is a 64-year male who came to Taylor Cancer Research Center following a diagnosis of Unresectable Metastatic Pancreatic Cancer.  He was referred to our Center in June of 2026 for consideration of clinical trial with precision therapy after he had been seen at Ohio State, University of Cincinnati and Indiana University.  He remembers thinking “We had no idea in the beginning what to expect.  No one comes to Maumee Ohio for treatment; they go to the James at OSU.  Once we met the staff we knew we were at the right place.”  

 

He started Cycle 1 Day 1 on 6/10/2026 under the care of Dr. Desai (Research Coordinator Jennifer Martinez).  After 16 weeks of treatment without any significant side effects, imaging showed a partial response.  His tumor had shown a 66% decrease in size.  Given the level of cancer decrease, Mr. Berheide underwent surgical evaluation and was felt to be a candidate for complete disease surgical resection.   

 

The patient met with the surgeon, and he is planning on having his resection at the end of November 2026.  When asked how he felt knowing that the cancer could be entirely removed, he stated “I am almost speechless.  I feel ecstatic, it still doesn’t seem real.”  

Next
Next

Renal Cell Carcinoma